Coretec Group Inc (CRTG)

[iamthe walrus]

The news of General Electric winning the Food and Drug Administrations approval ,September 3rd of this year ,for thier new 3D imaging product was Perhaps the biggest news of all.As we know General Electrics new 3D imaging solution called SenoClaire 3D tomosynthesis needs a way of viewing thier 3D data in real 3D, tomosynthesis is a new type of mammogram that produces a 3D image of the breast approved by the FDA back in February of 2011. SenoClaire is a new way of collecting 3D Data as this new device sweeps around the positioned breast,making nine exposures with a step and shoot method using low dose ,short x-ray bursts.The 3D data is then viewed once again off a 2D screen making 3Dicons C-Space real volumetric technology the perfect fit for viewing the 3D data being captured by General Electrics SenoClaire tomosynthesis machine.These types of data ,among others are the reason C-Space was developed ,to be able to properly view all the 3D data that is out there today.Its obvious why 3dicon made us aware of the F & D s approval of G.E.s SenoClaire tomosynthesis machine in the news release because C-Space fits perfectly with G.E.s new imaging device and for the medical imaging industry as a whole.